Gabrielle Zuniga, MD, PhD

Gabrielle Zuniga, MD, PhD, is a physician-scientist in the emergency medicine residency program at the University of Texas Health San Antonio. She earned a medical degree and a doctorate from the South Texas Medical Scientist Training Program at the University of Texas at San Antonio. Her work in the laboratory of Dr. Bess Frost focused on identifying mechanisms downstream of tau-induced neurodegeneration. Dr. Zuniga discovered that tau-induced deficits in ribonucleic acid (RNA) quality control are a novel pharmacologically targetable mechanism of neurodegeneration. She also played a key role in the development and completion of the clinical trial investigating the safety and feasibility of antiretroviral therapy in Alzheimer’s disease (ART-AD). Her current research interests are to elucidate tau-based mechanisms of neurodegeneration in the context of emergency medical care of patients after traumatic brain injury.